RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BIANCHI G
Collezione ASL Città di Torino

Items : 7

Predictors of Recurrence After Curative Surgery for Stage I Colon Cancer: Retrospective Cohort Analysis of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group. in Annals of surgery open : perspectives of surgical history, education, and clinical approaches / Ann Surg Open. 2024 Nov 18;5(4):e510. doi: 10.1097/AS9.0000000000000510. eCollection 2024 Dec.

2024
ASL Città di Torino
ASL Torino 3
AOU Città della Salute di Torino

Sica GS; Muratore A; Altomare DF; Montroni I; De Luca M; Spinelli A; Simone M; Persiani R; Spolverato G; Restivo A; de Manzini N; Braga M; Verlato G; Anania G; Tiberio GA; Milone M; Coco C; Ciarleglio F; de'Angelis N; Santarelli M; Trompetto M; Potenza E; Gallo G; Di Leo A; Crepaz L; Reddavid R; Rorato LM; Bianchi G; Zuolo M; et alii...

Prevalence of psoriatic arthritis in Italy: insights from the multicentric MAPSI study. in Frontiers in medicine / Front Med (Lausanne). 2025 Jan 6;11:1484988. doi: 10.3389/fmed.2024.1484988. eCollection 2024.

2024
ASL Città di Torino

Bergamini A; Tirri E; Rovera G; Santo L; Romeo N; Favero M; De Andres I; Iannone F; Epis OM; Roccatello D; Pendolino M; Tramontano G; Serban T; Foti R; Schenone C; Bianchi G;

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Oct 2;9(77):34639-34640. doi: 10.18632/oncotarget.26213. eCollection 2018 Oct 2.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Fabi A; Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Artale S; Blasi L; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; Ficorella C; Moretti G; Airoldi M; Sartori D; Valerio MR; Fumagalli A; Ciccarese M; Verusio C; et alii...

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431. eCollection 2018 Nov 30.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ? 65 years: new lessons for clinical practice from the EVA study. in Oncotarget / Oncotarget. 2018 Aug 7;9(61):31877-31887. doi: 10.18632/oncotarget.25874. eCollection 2018 Aug 7.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Cursano MC; Benedetto C; Turletti A; Atzori F; Piezzo M; Blasi L; Artale S; Bianchi G; La Verde N; Mentuccia L; Maur M; Vici P; Musolino A; Garrone O; Pistelli M; Generali D; Febbraro A; Zambelli A; Diodati L; Arcangeli V; Ficorella C; Moretti G; Airoldi M; Ancona C; Valerio MR; Sartori D; Fumagalli A; Ciccarese M; Verusio C; et alii...

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. in Breast (Edinburgh, Scotland) / Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.

2017
ASL Città di Torino
AOU Città della Salute di Torino

Sartori D; Scavelli C; Porpiglia M; Pistelli M; Palumbo R; Musolino A; Moretti G; Michelotti A; Maur M; La Verde N; Generali D; Gebbia V; Garrone O; Frassoldati A; Fumagalli A; Ficorella C; Ferzi A; Ferrari L; Fabi A; Piezzo M; Cursano MC; Ciccarese M; Campidoglio S; Blasi L; Bianchi GV; Ballerio A; Atzori F; Artale S; Arcangeli V; et alii...

Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? in Autoimmunity reviews / Autoimmun Rev. 2013 Jun;12(8):835-8. doi: 10.1016/j.autrev.2012.11.009. Epub 2012 Dec 3.

2013
ASL Città di Torino

Modena V; Bianchi G; Roccatello D;